GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (NAS:FLGT) » Definitions » Price-to-Tangible-Book

Fulgent Genetics (Fulgent Genetics) Price-to-Tangible-Book : 0.67 (As of May. 10, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Fulgent Genetics Price-to-Tangible-Book?

As of today (2024-05-10), Fulgent Genetics's share price is $21.79. Fulgent Genetics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $32.34. Hence, Fulgent Genetics's Price to Tangible Book Ratio of today is 0.67.

The historical rank and industry rank for Fulgent Genetics's Price-to-Tangible-Book or its related term are showing as below:

FLGT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.66   Med: 2.03   Max: 9.11
Current: 0.67

During the past 10 years, Fulgent Genetics's highest Price to Tangible Book Ratio was 9.11. The lowest was 0.66. And the median was 2.03.

FLGT's Price-to-Tangible-Book is ranked better than
90.42% of 167 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.49 vs FLGT: 0.67

A closely related ratio is called PB Ratio. As of today, Fulgent Genetics's share price is $21.79. Fulgent Genetics's Book Value per Sharefor the quarter that ended in Mar. 2024 was $37.79. Hence, Fulgent Genetics's P/B Ratio of today is 0.58.


Fulgent Genetics Price-to-Tangible-Book Historical Data

The historical data trend for Fulgent Genetics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Price-to-Tangible-Book Chart

Fulgent Genetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.35 2.58 2.83 0.90 0.88

Fulgent Genetics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 1.14 0.83 0.88 0.67

Competitive Comparison of Fulgent Genetics's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Fulgent Genetics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fulgent Genetics's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's Price-to-Tangible-Book falls into.



Fulgent Genetics Price-to-Tangible-Book Calculation

Fulgent Genetics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=21.79/32.337
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Fulgent Genetics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Fulgent Genetics (Fulgent Genetics) Business Description

Traded in Other Exchanges
Address
4978 Santa Anita Avenue, Temple City, CA, USA, 91780
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Executives
Jian Xie officer: Chief Operating Officer C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVE, EL MONTE CA 91731
Hanlin Gao 10 percent owner, officer: Chief Scientific Officer 4399 SANTA ANITA AVE., EL MONTE CA 91731
Paul Kim officer: CFO and Treasurer 4399 SANTA ANITA AVE, EL MONTE CA 91731
Regina E Groves director 5751 COPLEY DRIVE, SAN DIEGO CA 92111
Leonard E Post director
Michael Nohaile director C/O BIO AI ACCELERATION COMPANY, 20 UNIVERSITY AVENUE, CAMBRIDGE MA 02138
John C Bolger director 4978 SANTA ANITA AVENUE, SUITE 205, TEMPLE CITY CA 91780
Ming Hsieh Trust 10 percent owner 4399 SANTA ANITA AVE., EL MONTE CA 91731
Linda Marsh director 100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801
Ming Hsieh director, 10 percent owner, officer: President and CEO 4399 SANTA ANITA AVE., EL MONTE CA 91731
Fulgent Genetics, Inc. director 4399 SANTA ANITA AVE, EL MONTE CA 91731
Yun Yen director 1301 OAKLAWN ROAD, ARCADIA CA 91006
James Mulay director 6521 THOROUGHBRED LOOP, ODESSA FL 33556
Xi Long Usa, Inc. 10 percent owner #6 XINRUI RD., SCIENCE CITY, LUOGANG DISTRICT, GUANGZHOU CITY F4 510663

Fulgent Genetics (Fulgent Genetics) Headlines

From GuruFocus

Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel

By Business Wire Business Wire 02-28-2023

Insider Alert: An Insider Just Sold Fulgent Genetics Inc Shares

By GuruFocus Research GuruFocus Editor 05-21-2023